Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
461 studies found for:    "Bone cancer"
Show Display Options
Rank Status Study
1 Unknown  Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
Conditions: Bone Cancer;   Bone Metastases;   Pain
Intervention: Device: ExAblate 2100
2 Unknown  Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Conditions: Bone Cancer;   Bone Metastases;   Pain
Interventions: Device: Exablate treatment;   Radiation: Radiation
3 Completed Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
Conditions: Osteosarcoma;   Localised High Grade Osteosarcoma of the Limbs
Interventions: Drug: Etoposide, Ifosfamide, Methotrexate;   Drug: Doxorubicin, Methotrexate
4 Completed Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Conditions: Metastatic Osteosarcoma;   Relapsed Osteosarcoma
Interventions: Drug: Sorafenib;   Drug: Everolimus
5 Recruiting Study of Blood Samples From Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
6 Recruiting Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Conditions: Osteosarcoma;   Metastatic Osteosarcoma
Intervention: Drug: pazopanib
7 Recruiting Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Conditions: Osteosarcoma;   Paget's Disease;   Ewing Sarcoma
Intervention: Other: DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI
8 Not yet recruiting Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Osteosarcoma
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis
9 Active, not recruiting Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: cisplatin;   Drug: methotrexate;   Procedure: therapeutic conventional surgery;   Biological: peginterferon alfa-2b;   Drug: ifosfamide;   Drug: etoposide;   Procedure: quality-of-life assessment;   Other: questionnaire administration
10 Recruiting Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Conditions: Cancer;   GCT;   Giant Cell Tumor of Bone;   Benign GCT
Intervention: Drug: Denosumab
11 Completed Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Ifosfamide, Carboplatin, Doxorubicin;   Procedure: Limb Sparing
12 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: 153Sm-EDTMP;   Other: Autologous Peripheral Blood or Bone Marrow Stem Cell Infusion;   Radiation: External Beam Radiotherapy
13 Terminated A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
Conditions: Osteosarcoma;   Lung Metastases
Interventions: Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: G-CSF;   Drug: PEG-filgrastim;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna;   Drug: Leucovorin
14 Completed Phase II Study of Intravenous Rexin-G in Osteosarcoma
Condition: Osteosarcoma
Interventions: Genetic: Rexin-G Dose 1;   Genetic: Rexin-G Dose 2
15 Unknown  Diffusion Study on Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention:
16 Completed Sorafenib in Relapsed High Grade Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: sorafenib
17 Completed Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Etoposide;   Drug: Interferon Alpha
18 Completed Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
Condition: Osteosarcoma
Intervention: Drug: pre-surgical chemotherapy
19 Active, not recruiting A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Chemotherapy;   Drug: Endostar
20 Completed Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Methotrexate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years